These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11810945)

  • 1. [Sandostatin efficiency in the enzymatic phase of acute pancreatitis].
    Tolstoĭ AD
    Khirurgiia (Mosk); 2001; (12):58-61. PubMed ID: 11810945
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative characteristics of octreotide and famotidine in the treatment of acute pancreatitis].
    Bagnenko SF; Rukhliada NV; Tolstoĭ AD; Gol'tsov VR; Nazarov VE
    Vestn Khir Im I I Grek; 2002; 161(6):26-9. PubMed ID: 12638487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A trial of the use of sandostatin in patients with chronic pancreatitis].
    Loginov AS; Sadokov VM; Vinokurova LV; Chernoiarova OD; Astaf'eva OV; Nilova TV
    Ter Arkh; 1995; 67(7):60-2. PubMed ID: 7482309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of Sandostatin in the combined treatment of acute destructive pancreatitis].
    Lysenko MV; Meshkov VV; Ursov SV; Kuznetsova IV; Nikiforova DM
    Voen Med Zh; 1997 Jan; 318(1):68-70. PubMed ID: 9254475
    [No Abstract]   [Full Text] [Related]  

  • 5. [The administration of sandostatin in the combined treatment of acute pancreatitis and its complications].
    Saenko VF; Lupal'tsov VI; Babenkov GF; Kopchak VM; Volzhanskiĭ AP
    Klin Khir; 1999; (10):5-7. PubMed ID: 10584505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of octrestatin in the treatment of patients with acute pancreatitis].
    Riazanov DIu
    Klin Khir; 2005 Sep; (9):15-7. PubMed ID: 16445037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylactics of acute pancreatitis in pancreatic-duodenal resection].
    Demin LI; V'iushkov DM; Minaev II; Propp AR; Zamorov AG
    Vestn Khir Im I I Grek; 2002; 161(5):40-2. PubMed ID: 12661246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of octreotide on the clinical course of acute pancreatitis and levels of free oxygen radicals and antioxidants].
    Lata J; Dítĕ P; Julínková K; Precechtĕlová M; Prásek J
    Vnitr Lek; 1998 Sep; 44(9):524-7. PubMed ID: 10358462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sandostatin treatment of destructive pancreatitis].
    Ivanov IuV
    Klin Med (Mosk); 1999; 77(9):37-9. PubMed ID: 10599225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of plasma levels of gastrointestinal peptides over the course of acute pancreatitis. Any significance for the pathophysiology and treatment of acute pancreatitis?
    Nikou GC; Giamarellos-Bourboulis EJ; Toumpanakis C; Arnaoutis TP; Kitsou E; Kyriaki D; Katsilambros N
    Hepatogastroenterology; 2002; 49(45):706-8. PubMed ID: 12063974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The potentials for using sandostatin in gastroenterology (a review)].
    Lopatkina TN
    Ter Arkh; 1995; 67(7):66-8. PubMed ID: 7482311
    [No Abstract]   [Full Text] [Related]  

  • 12. [Application of octreotide in patients with acute pancreatitis].
    Shor NA; Levina VP; Ioffe IV; Andreeva IV; Chumak IuF; Zhadanov VI; Zelenyĭ II
    Klin Khir; 2004 Feb; (2):15-7. PubMed ID: 15124466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
    Wu SF; Chen AC; Peng CT; Wu KH
    Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of sandostatin on sphincter of Oddi in acute severe pancreatitis in dogs].
    Zhu Q; Yuan Y; Xia L; Xu J
    Zhonghua Nei Ke Za Zhi; 1999 Nov; 38(11):747-9. PubMed ID: 11798715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of octreotide and somatostatin in acute and chronic pancreatitis.
    Uhl W; Anghelacopoulos SE; Friess H; Büchler MW
    Digestion; 1999; 60 Suppl 2():23-31. PubMed ID: 10207228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of the dosage adjustment of octreotide in the treatment of acute pancreatitis of moderate severity.
    Nikou GC; Arnaoutis TP; Giamarellos-Bourboulis EJ; Samolada O; Vafiadis-Zouboulis I; Katsilambros N; Arvanitakis C
    Hepatogastroenterology; 2001; 48(42):1754-7. PubMed ID: 11813617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intravenous octreotide treatment for acute experimental pancreatitis.
    Greenberg R; Haddad R; Kashtan H; Brazowski E; Graff E; Skornick Y; Kaplan O
    Digestion; 1999; 60(2):125-31. PubMed ID: 10095153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Repetitive acute pancreatitis in a late-diagnosed cystic fibrosis: prevention of relapses by octreotide in the long term].
    Weber A; Queneau PE; Polio JC; Koch S; Fellmann F; Sauve G; Carayon P
    Gastroenterol Clin Biol; 2001 May; 25(5):546-8. PubMed ID: 11521109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytokine profile in patients with chronic alcohol pancreatitis].
    Vinokurova LV; Tsaregorodtseva TM; Banifatov PV; Zhivaeva NS; Serova TI; Nilova TV
    Eksp Klin Gastroenterol; 2003; (6):54-7. PubMed ID: 15065529
    [No Abstract]   [Full Text] [Related]  

  • 20. [The therapeutic applications of octreotide].
    Carrera-Hueso FJ; Carrera-Hueso JA; Llorente I
    Med Clin (Barc); 1996 Apr; 106(13):505-16. PubMed ID: 8992134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.